02. Breast Disease Flashcards

1
Q

What hormones cause cyclical breast changes?

A

Estrogen & progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an independent factor of breast cancer risk?

A

Breast density (4-6x increase in breast cancer risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a better imaging modality for women with dense breasts?

A

MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the drawbacks of using MRI for breast imaging?

A

May lead to more interventions for benign conditions; Tricky get insurance coverage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Whatis the approach for analyzing a breast abnormality?

A

Triple test (triple negative)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the components of the triple test?

A

Breast exam; Imaging; Tissue sampling (FNA or Core needle bx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 Common Benign Breast Diseases

A

Fibrocystic Changes (FCC) including cysts; Fibroadenomas; Mastitis/Abscess; Nipple d/c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fibrocystic Changes

A

Breast tissue response to cyclic hormonal changes; Changes are benign but frightening; Cyclic pain, nodularity, nipple d/c, microscopic & gross changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Breast cysts

A

Painful, fluctuant, mobile masses, W/O REDNESS. Can be exquisitely tender; Confirm with U/S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Breast cyst tx

A

Aspirate with 23-25 gauge needle after injecting 1% lidocaine; send fluid to cytology if not clear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fibroadenoma

A

MC tumon in women over 25; Firm, round, mobile, NONTENDER mass anywhere in breast. Dx with triple test.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fibroadenoma tx

A

Remove if growing, >3cm, or bothersome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Breast abscess

A

Common in LACTATING women. PAINFUL, hard RED mass. Usually caused by S. aureus. Often chronic or recurrent, esp. retro alveolar.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Breast abscess dx & tx

A

Aspirate to confirm dx; I & D + bx to r/o CA; ABX if needed. During lactation, mechanically empty breast and temporily d/c nursing in affected breast only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Common etiology of milky nipple d/c

A

Lactation, prolactinoma, post-lactational changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Common etiology of serous, brown, gray, green nipple d/c

A

Fibrocystic changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Common etiology of bloody, blood-tinged, or SEROUS nipple d/c

A

Intraductal papilloma; CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Milky, unlateral nipple d/c tx

A

No tx necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Milky, bilateral nipple d/c tx

A

If greater than 2 yr since lactation, check plasma prolactin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Bloody nipple d/c tx

A

Excisional bx of draining duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Paget’s disease of the nipple

A

Rare form of breast CA that begins in the MILK DUCTS and spreads to the skin of the NIPPLE & AREOLA. Accounts for 1% of breast cancer. Breast skin may appear CRUSTED, RED, OR OOZING. Prognosis may be better if NIPPLE CHANGES ARE ONLY SIGN OF BREAST DISEASE and no lump is felt.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Fat necrosis presentation

A

Firm to hard palpable mass that feels like CA and can look like CA on mammogram. Caused by trauma or post-surgical. Usually doesn’t resolve or change. Bx proves non-malignant. Ask pt if she suffered any chest wall trauma. Common in elective reductions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mammary Duct Etasia

A

Dilation of the mammary ducts causing unilateral or bilateral d/c (green, black, brown & thick); Benign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Galactocele

A

“milk” tumor or cyst. Tx with fluid aspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Cancer in pregnancy

A

Hormone responsive tumors grow rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Mastodynia/Mastalgia

A

Extremely common complaint. 7-10% of breast CA presents with this as only sx. R/O trauma, costochondritis; breast mass; CA; AMI. Left breast pain may be a sign of AMI.

27
Q

Tx of mastalgia

A

Analgesics; warm showers/compresses; supportive bra; evening primrose oil

28
Q

Gynecomastia

A

Do a testicular exam; may be a testicular tumor causing hormonal imbalance leading to breast development, esp. in older men. May also be d/t meds or liver disease.

29
Q

Male Breast CA

A

Ask about breast pain, swelling, mass, family hx of breast and ovarian CA, esp. hx of male breast CA.

30
Q

Risk factors for Male Breast CA

A

Family hx; Klinefelter’s syndrome (XXY); radiation exposure; liver dz; estrogen tx

31
Q

Signs of early breast cancer on mammogram

A

Microcalcifications +/- nonpalpable mass

32
Q

Clinical signs of breast cancer

A

Lump or thickening of breast or axillary LN; Change in breast size/shape; Nipple d/c, inversion, or axis change; Redness of skin, lymphedema

33
Q

Lifetime risk of developing breast cancer

A

1 in 8 by age 85

34
Q

What is the most common way of finding breast cancer?

A

Breast self examination (70%).

35
Q

Bx method for diagnosing breast abnormalities

A

Core biopsy is accepted method

36
Q

DCIS

A

Ductal carcinoma in situ; Bx result that is tx like a cancer. MOST COMMON type of non-invastive breast CA. CONFINED TO DUCTS OF BREASTS. Detected as microcalcifications on mammography. 30% total lifetime risk of developing invasive carcinoma w/o tx.

37
Q

LCIS

A

Lobular carcinoma in situ; Bx result that is NOT TX like a cancer. HIGH RISK MARKER! Sharp increase in # of cells within the milk glands (lobules) of the breast. Carries 30% lifetime risk of invasive carcinoma, but can develop anywhere in breast.

38
Q

IDC

A

Infiltrating Ductal Carcinoma; AKA Invasive ductal carcinoma. Bx result showing ductal cancer. MOST COMMON invasive breast cancer. Begins in milk ducts of breast and penetrates wall of the duct, invading fatty tissue.

39
Q

ILC

A

Infiltrating Lobular Carcinoma; Bx results confirming lobular cancer

40
Q

In what tissue does breast cancer most commonly present?

A

Ductal tissue

41
Q

HER2 Receptors

A

Breast cancer tumor marker that helps ID meds that will work on the tumor, SPECIFICALLY Herceptin (trastuzumab) & predicts response to anthracyline based adjuvant or metastatic tx

42
Q

Single greatest predictor of breast cancer survival

A

The presence or absence of axillary lymph node metastasis.

43
Q

ALND

A

Axillary lymp node dissection - Remove LNs from level 1 & 2 of axilla & look for signs of metastatic disease.

44
Q

ALND adverse effects

A

Significant lymphedema, parathesia, and limited arm mobility; no venipuncture of arm

45
Q

When is ALND required?

A

Inflammatory breast CA & tumors >5cm

46
Q

SLNB

A

Sentinel Lymph Node Biopsy - Sample the one node that drains the breast; much less risk of lymphedema.

47
Q

SLNB indications

A

Small tumors (

48
Q

Most common sites of breast cancer metastases

A

Brain, bone, liver & lung

49
Q

Visceral mets

A

Worse prognosis;

50
Q

Stage IIIA (T3, N1, M0) workup

A

Bone scan, Abdominal pelvis CT, U/S, or MRI; Chest imaging; Head imaging if brain met suspected

51
Q

Who should be referred to genetic counseling? Why?

A

High risk pts. - Risk reduction strategies & tx

52
Q

Breast cancer tx options (general)

A

Local (surgery; radiation) & Systemic (chemo; hormonal therapy)

53
Q

Use of neoadjuvant chemo

A

Before surgery to shrink large tumors to make them operable or to make small tumors eligible for lumpectomy

54
Q

Use of polychemotherapy

A

Infiltrating breast cancer; Usually a 3-4 drug regimen. Never just 1 drug. Improved outcomes in 15 yr recurrence & death rates.

55
Q

Which women see more benefits from polychemotherapy?

A

Younger women benefit more than older women.

56
Q

What is the overall purpose of chemotherapy?

A

Eradicated clinically occult metastases.

57
Q

When is hormonal tx standard adjunct therapy?

A

In all patients with hormone receptor positive breast cancer; prevents breast cells from receiving endogenous estrogen stimulation

58
Q

What SERM is approved for all stages of hormone responsive breast cancer?

A

Tamoxifen

59
Q

What drug can be used for prevention of hormone responsive breast cancer in high risk patients?

A

Tamoxifen

60
Q

What is the standard treatment regimen for Tamoxifen?

A

20 mg/day for 5 yrs after completion of chemo & radiation tx

61
Q

What are side effects of tamoxifen?

A

Hot flashes & increased risk of thromboembolic events & endometrial cancer. Avoid use in smokers and post-menopausal women.

62
Q

Aromatase inhibitors MoA and Use

A

Prevent conversion of androgens to estrogen in postmenopausal women; AIs are recommend adjuvant tx for post-menopausal breast cancer

63
Q

When is radiation therapy indicated?

A

DCIS + lumpectomy + whole breast radiation; Invasive breast cancer + whole breast radiation following chemo; BCT & post-mastectomy indications

64
Q

Most commonly used breast cancer treatment guidelines

A

National Comprehensive Cancer Network (NCCN)